Wells' Criteria for Pulmonary Embolism
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–1
- Intermediate Risk2–6
- High Risk6.5–12.5
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Venous Thromboembolism & PE — ترومبوآمبولی ورید عمقی و آمبولی ریه
Clinical Rationale:
Stratify PE risk using Wells and Geneva scores; safely rule out low-risk PE with PERC, interpret age-adjusted D-dimer and YEARS algorithm, and determine 30-day mortality with PESI.
Recommended Clinical Next Steps:
Geneva Score (Revised) for Pulmonary Embolism
امتیاز ژنو (تجدیدنظرشده) برای PE
Why next: Independent clinical probability confirmationAltitude-Adjusted PERC Rule
قاعده PERC (تنظیمشده با ارتفاع)
Why next: Safe rule-out of PE without D-dimerAge-Adjusted D-dimer for Venous Thromboembolism (VTE)
دی-دایمر تعدیلشده بر اساس سن
Why next: Optimize D-dimer cutoff over age 50
The Wells' Criteria for Pulmonary Embolism calculates stratifying pneumonia severity, respiratory failure progression, and inpatient admission requirements. Key inputs include clinical signs dvt. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Clinical pretest probability score for pulmonary embolism based on seven bedside criteria; supports both 3-tier (low/intermediate/high) and 2-tier (PE unlikely/likely) interpretations to guide D-dimer testing and imaging decisions
Clinical Indication
The Wells' Criteria for Pulmonary Embolism is indicated for bedside clinical practice to support Clinical pretest probability score for pulmonary embolism based on seven bedside criteria; supports both 3-tier (low/intermediate/high) and 2-tier (PE unlikely/likely) interpretations to guide D-dimer testing and imaging decisions. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.
Limitations & Contraindications
Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia. Clinical exclusion: Use D-dimer to safely exclude PE in low or intermediate probability patients; proceed directly to imaging in high probability patients..
Clinical Pearls & Action Plan
Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.
Score = Clinical signs of DVT (3.0) + PE most likely diagnosis (3.0) + Heart rate >100 bpm (1.5) + Immobilization ≥3 days or surgery within 4 weeks (1.5) + Previous DVT/PE (1.5) + Hemoptysis (1.0) + Active malignancy (1.0)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| clinical_signs_dvt | string | Yes | Clinical signs and symptoms of deep vein thrombosis (e.g., unilateral leg swelling and pain with palpation of the deep veins) |
| pe_most_likely | string | Yes | Pulmonary embolism is the most likely diagnosis (alternative diagnosis less likely than PE) |
| heart_rate_over_100 | string | Yes | Heart rate greater than 100 beats per minute |
| immobilization_surgery_recent | string | Yes | Immobilization for ≥3 days or surgery within the previous 4 weeks |
| previous_dvt_pe | string | Yes | Previous history of deep vein thrombosis or pulmonary embolism |
| hemoptysis | string | Yes | Hemoptysis (coughing up blood) |
| active_malignancy | string | Yes | Active cancer (treatment ongoing, within 6 months, or palliative) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–1 | Low Risk | Low clinical probability of PE |
| 2–6 | Intermediate Risk | Intermediate clinical probability of PE |
| 6.5–12.5 | High Risk | High clinical probability of PE |
Evidence-Based References (EBM)
- Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med. 2001;135(2):98-107.
- van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295(2):172-179.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.